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9The Challenges of Implementing Packaged Hospital Electronic Prescribing 
and Medicine Administration Systems 
in UK Hospitals: Premature Purchase 
of Immature Solutions?
Hajar Mozaffar, Robin Williams, Kathrin M. Cresswell, 
Neil Pollock, Zoe Morrison, and Aziz Sheikh
9.1  Introduction
This chapter explores the difficulties experienced in recent attempts to implement 
‘packaged’ Hospital Electronic Prescribing and Medicine Administration (HEPMA) 
systems in NHS England. Though electronic prescribing was originally conceived 
as a pharmacy technology, it has become the occasion for integrating various other 
kinds of digital information (e.g. laboratory test results) at the point of care and for 
sharing this information across the care pathway. HEPMA in the United Kingdom 
(UK) has thus served as a stepping stone in developing hospital-wide infrastructures 
that directly support both diagnosis and care delivery. Considerable effort was 
needed to integrate HEPMA modules within the hospital information 
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infrastructures and to interface them with external systems – and other parts of the 
health system, notably primary care. The difficulties besetting attempts to imple-
ment HEPMA as Commercial Off The Shelf (COTS) packaged software have high-
lighted the gap between the generic workflow models embedded in standardised 
COTS solutions (many of which were developed overseas) and the diverse practices 
of particular UK hospitals. Similar problems arose with previous attempts to imple-
ment packaged enterprise systems (ES), but were ameliorated through a protracted 
social learning (Sørensen 1996)  process involving vendors, suppliers and various 
intermediaries. Comparing HEPMA and ES highlights the current immaturity of the 
HEPMA market. This is characterised by: the relatively embryonic linkages between 
HEPMA vendors and their potential market of users; users’ lack of understanding 
of the exigencies of exploiting packaged solutions; vendors’ limited understanding 
of user requirements and poorly elaborated strategies to address diverse user needs 
in generic solutions.
Stakeholders managing health systems in many countries have invested substan-
tial efforts to implement and deploy electronic or ePrescribing systems (Mozaffar 
et al. 2014; Cresswell et al. 2013) to support prescribing decisions in health organ-
isations (Aarts and Koppel 2009; Bates et al. 1998). The National Health Service 
(NHS) in England has similarly invested considerable resources in these systems. It 
describe these systems as:
The utilisation of electronic systems to facilitate and enhance the communication of a pre-
scription or medicine order, aiding the choice, administration and supply of a medicine 
through knowledge and decision support and providing a robust audit trail for the entire 
medicines use process. (NHS Connecting for Health, England)
9.1.1  The UK Context for Hospital Electronic Infrastructures
Health care in the UK is primarily provided through the publicly-funded National 
Health Service (NHS). With over a million employees, the NHS is an exceptionally 
large and complex organisation (Hibberd et al. 2016). There are differences between 
the NHS in each of the devolved administrations (England, Scotland, Wales, 
Northern Ireland). This chapter focuses on developments within NHS England, 
which is by far the largest. Hospitals are run by regional health  authorities, originally 
known as Primary Care Trusts, with primary care delivered by multiple independent 
General Practitioners. Despite a very long history of  hospital computerisation 
stretching over 60 years, the development of hospital electronic infrastructures was 
seen to be held up, inter-alia, by the  fragmentation of procurement between hospi-
tals and trusts. Repeated attempts to improve integration culminated in a major 
national initiative: the National Programme for Information Technology (NPfIT) in 
which, as well as creating a central transaction processing ‘Spine’ (Hibberd et al. 
2016), selected software applications were to be centrally procured and implemented 
in NHS hospitals (Sheikh et al. 2011; Robertson et al. 2011). This initiative however 
encountered numerous problems and, as a result, the Department of Health instituted 
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a change of direction from a ‘centrally driven strategy of replace all’ to ‘locally cho-
sen and implemented systems’ (Robertson et al. 2011; Sheikh et al. 2011).
NHS calls to improve the quality, safety and efficiency of healthcare, coupled 
with substantial financial support, have provoked widespread interest in the 
timely implementation of HEPMA systems in UK hospitals (Buntin et al. 2011; 
Black et al. 2011; McKibbon et al. 2011) and attracted a number of UK and 
overseas suppliers. Electronic prescribing is already well established in 
England’s primary care (Avery et al. 2007; Fernando et al. 2004; Hibberd et al. 
2016). Over the last decade, several attempts have been made to implement 
HEPMA systems in secondary care. In 2013 only 13% of hospitals had hospital-
wide HEPMA systems (Ahmed et al. 2013). This is however expected to rise 
rapidly as a result of the £500 Million Safer Hospitals Safer Wards technology 
fund launched in 2013 and a policy target of complete implementation across the 
NHS by 2020 (Carter 2015). The move towards local selection of systems has 
resulted in hospitals being faced with a range of options, none of which are how-
ever currently perceived as fully meeting the needs of the English market 
(Mozaffar et al. 2014).
Whilst the first generation of HEPMA systems was developed within hospitals, 
today we see a marked shift away from home-grown solutions towards COTS ‘pack-
aged’ software (Mozaffar et al. 2014). There are a number of reasons for this move. 
These include the very substantial costs associated with developing and maintaining 
bespoke systems (and the stalled progress and anticipated failure of a flagship proj-
ect to jointly develop an integrated solution within/for English hospitals1), the per-
ceived advantages of packaged solutions (in terms of functionality/price, 
dependability, maintenance) and problems with limited interoperability between 
providers (Schiff et al. 2003; Westbrook et al. 2012). However, standard COTS 
solutions, built around generic models of the user organisation, may be far removed 
from the workflows of particular adopter organisations, necessitating a considerable 
effort to configure and customise software or to adjust local working practices 
(Pollock and Williams 2008). Despite these investments, the HEPMA market in 
England is faced with a great deal of uncertainty and is undergoing rapid change and 
evolution (Aarts and Koppel 2009; Mozaffar et al. 2014). As well as intense policy 
pressures and incentives to adopt HEPMA, hospitals are confronted by the lack of 
maturity of current supplier offerings, their limited tailoring to the English context, 
the diversity of systems and lack of knowledge about the available options. These 
factors all contribute to the challenges that hospitals face in procuring, 
implementing and realizing the benefits of these systems (Wolfstadt et al. 2008; 
Bates et al. 2003; Cresswell et al. 2013; Mozaffar et al. 2014).
1 Thus the Lorenzo patient system being collaboratively developed under NPfIT encountered such 
serious delays that its wide adoption is seen as increasingly unlikely. Tameside Hospital NHS 
Foundation Trust recently awarded the highest possible risk rating to its Lorenzo project, citing 
“potential risks to patient safety quality, information governance and performance trajectories” 
(HSJ 2014).
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In this chapter we examine the problems that have arisen in the supply, procure-
ment and implementation of packaged HEPMA solutions. We explore the reasons 
for this in terms of the state of development of the HEPMA market – encompassing 
the strategies and capacities of both vendors and adopters. Our analysis brings to 
bear insights from the Biography of Artefacts and Practices (BoAP) perspective 
(Pollock and Williams 2008) that emerged from our previous long-term programme 
of research into the evolution of the Enterprise System market. BoAP draws also 
upon recent related analytical advances in relation to the conceptualization of 
information infrastructures and to the formation and maturation of technological 
fields. As we outline below, this suggests that analysis of the development of infor-
mation infrastructures (IIs) needs to engage with the exigencies surrounding tech-
nology supply and the increasing resort to commercially-supplied solutions. For 
example (Koch 1997), highlighted the choice between “bricks and clay” when 
building corporate IIs: between procuring integrated solutions or configuring 
together large numbers of small infrastructure components. The latter offers greater 
scope for adopter organisations to exercise choice in the selection of components 
and (because they tended to be technologically simpler) greater potential influence 
over their design. Integrated solutions offered less flexibility but transferred the 
integration challenge to the supplier. They could also operate as a platform onto 
which other offerings might be erected (Koch 2007). This in turn suggests that 
theories of the installed base need to go beyond a focus on the evolution of indi-
vidual IIs and take on board the complex sets of relations linking multiple vendors 
and their adopter communities. We will explore this conceptual framework in our 
Discussion.
Methods
This chapter draws upon an extended national research programme investi-
gating the implementation and adoption of HEPMA systems in English hos-
pitals funded by the National Institute for Health Research (NIHR). In this 
chapter we re-examine these findings in relation to the goals of this book to 
understand the development of health infrastructures and examine the influ-
ence of the installed base.
We draw particularly upon a study of the current status of the English 
HEPMA market (Mozaffar et al. 2014, 2015; Cresswell et al. 2013; Crowe 
et al. 2010). We collected qualitative data from both suppliers and adopters of 
various HEPMA systems in England. Data collection, undertaken over the 
period October 2012 to October 2014, involved a combination of semi- 
structured interviews with staff of six English hospitals adopting HEPMA and 
of four system vendors, ethnographic observations (totalling 21 h) of user 
groups and hospital practices, a supplier round-table discussion, and collec-
tion of publically available documents. Interviews and data analysis were con-
ducted in tandem – research foci and theme emerged inductively over a number 
of iterations. Table 9.1 summarises the data sources and collection methods.
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9.2  Understanding the Uneven Success of HEPMA
Overall there had been a relatively low uptake of these products by English hospi-
tals and implementation has been slow (Mozaffar et al. 2014). This market was 
undergoing rapid cycles of change with many suppliers entering and offering a wide 
range of products in terms of functionality and architecture. Our analysis suggests a 
range of explanations for the current uneven growth and variable success of HEPMA 
systems in England, rooted in suppliers’ strategies and adopters’ current reactions to 
the technology and the market.
9.2.1  How HEPMA Systems Are Constituted: Extension of Non- 
clinical Systems
Our earlier study on the spectrum of available HEPMA systems in England identi-
fied a wide range of systems including 13 hospital-wide applications and a range of 
specialty systems in implementation or use across English hospitals (Mozaffar et al. 
2014). Nine of these systems were developed outside England and were introduced 
into the English market over the past decade.
We studied four HEPMA systems. None were initially designed as HEPMA 
systems.
One of the products in our sample involved a pharmacy stock control system, 
which was extended with the addition of HEPMA functionality including what is 
sometimes described as computerized physician order entry (CPOE) and 
Table 9.1 Data collection methods
Method Data source Focus of enquiry
Semi-structured 
interviews (ranging 
from 45 min to 2 h)
Four suppliers (a) The current status and trajectory of growth of 
HEPMA systems in England;
Six hospitals (b) Strategies in design, development and 
adaptation (Anglicization) of the system;
(c) The problems faced during implementation 
and their possible causes; and
(d) The supplier-user relationship throughout the 
project lifecycle
Observations Two user group 
meetings
(a) The technological contents of the discussion;
(b) The supplier-user relationships; and
(c) Decisions being taken.
Focus group Supplier 
round-table 
discussion
(a) Challenges and opportunities for suppliers 
from the early stages of project initiation to 
implementation;
(b) Suppliers’ experiences of go-live and system 
stabilization; and
(c) Suppliers’ views on system optimization and 
enhancements
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computerized decision support (CDS). This medication-focused system offered 
basic integration between the two modules but it was not a fully integrated hospital 
information system. This was a standalone application that covered inpatient needs, 
discharge prescribing, and pharmacy stock control. Interfacing strategies were used 
to connect this system with other systems used in hospitals. During this the course 
of this study, plans were made to extend this system by designing and developing 
the discharge prescribing system.
There were two multi-modular integrated ‘systems’, which arose through the 
expansion of insurance or billing systems for U.S. hospitals into integrated hospital- 
wide systems with the additional modules covering various areas such as inpatient 
and outpatient prescribing, electronic medical record, clinical imaging and labora-
tory, linked into an integrated whole with one underlying database. The final system 
was initially designed as an electronic patient chart system and then expanded over 
time to include a scheduling system and HEPMA modules (initially only inpatient 
prescribing, though during the course of this study, plans were made to extend this 
system by designing and developing the discharge prescribing system). Thus, we 
saw that the promotion of HEPMA functionalities had pulled in product offerings 
and component technologies from different sources with different historical paths, 
which resulted in packages with rather different architectures and configurations.
Members of adopting organisations noted that the two U.S. ‘integrated systems’ 
emerged by adding multiple modules to what was originally a billing/insurance 
management system, formed around calculating the costs of drugs and saw this as 
an important factor in the problems in implementing and using these systems. They 
often described these as ‘non-clinical systems’, to draw attention to the fact that 
they arose as an extension of an already existing product with a different focus.
…over the years they have progressed from the original billing system or pharmacy stock 
control systems to now be basically sold as EPMA [ePrescribing and medication adminis-
tration] systems …. It’s just a billing system… the funding for the hospital was gained rais-
ing bills from the patients they treated. So they needed a full audit trail to know what went 
on with the patient so they can charge the right amount of money. So again they were origi-
nally billing systems but they started to tag on clinical functionality on them (Adopter 
Interview, P1)
These users questioned the clinical merits of offerings that were not initially 
designed as clinical systems, but emerged by adding HEPMA functionality to non- 
clinical systems:
…in recent times there has been a lot more influx on the market. The EPMA systems are 
generally changing to focus on the clinical functionality… but whether you could say that 
the system is totally designed around the clinical users interface is a debatable question… 
if you want something to be a clinical tool then it should be clinical enabling and not some-
thing like clinical disabling … do we want to collect clinical information to make clinical 
judgment better or do we want it to manage the process that we are doing when we are 
trying to treat patients (Adopter Interview, P1)
The non-clinical origins of these systems were seen as resulting in interface designs 
and workflows that were not centred around patient care pathways. A clinician, 
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using the HEPMA system built around a stock control system, felt that system 
design might usefully take a different starting point:
…our starting point is not just prescribing a drug, our starting point is actually saying you 
come in with this condition therefore your pathway is this. (Adopter Interview, P2)
We observed a wide range of HEPMA systems shaped by the history through which 
they were constituted. In general the trend was to add HEPMA functionalities to 
already existing (non- ePrescribing) systems or to adapt existing systems to accom-
modate the newly required functions. These systems had inherited some of the char-
acteristics of their source system and this affected their usability. Despite significant 
technical differences between the solutions, we encountered homologous problems. 
In particular, in the process of expanding the scope of systems, suppliers seemed to 
have underestimated the complexity of HEPMA as a clinical system and the par-
ticularity of user activities (a failing that closely mirrored criticisms of early ES 
offerings two decades earlier).
9.2.2  Adoption of Systems That Had Been Developed 
Outside England
Mozaffar et al. (2014) highlighted that more than half of the systems available in 
England originated in other countries. Respondents attempting to implement these 
systems in English hospitals frequently drew our attention to this point which they 
saw as representing a major problem, as:
…their [US] way of working is very different to the U.K. based working (Adopter 
Interview, P2)
The lack of alignment between ‘foreign’ supplier offerings and UK hospitals’ inter-
nal processes and needs was seen as a major barrier to implementing these 
systems.
…[Product Name] is a U.S. system and it works very well for a U.S. hospital, but some 
things in the U.K. are quite different specially around medicines practices and we are still 
working with [Supplier Name] to see if we can get some of their products changed to better 
reflect our workflow (Adopter Interview, P4)
This became clearer when adopters expressed a desire to see England-specific solu-
tions being developed around ‘generic’ English hospitals’ needs.
In terms of medicine there are a number of issues we have with [Product Name] and most 
of these are issues that aren’t just local to [Place Name] they’re issues that we think are 
indicative across other U.K. sites… (Adopter Interview, P4)
Well a lot of it is U.S.-based but they have to customize it to the U.K. market because we 
are different, so I mean that’s why we have had a number of meetings with them and with 
the [Product Name] user group to explain, you know, we’re different and they know this but 
we keep having to remind them. (Adopter Interview, P5)
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Overseas suppliers emphasized that they were aware of the differences between the 
two countries and highlighted that they had particular ways of catering for these 
needs, in particular by offering England-specific versions of the application.
An interface to a formulary vendor for medications is standard in the U.S. but we obviously 
had to go above and beyond knowing that there are different requirements, there’s different 
information on drugs in the U.K., you know, how they’re numbered and tracked is different, 
you know, DM&D [Dictionary of Medicines and Devices – unique identifier given by NHS] 
number does not exist in our U.S. software (Supplier Interview, P6)
However, despite pressure from hospitals and end-users, participants in user group 
meetings complained that many suppliers had been slow to create England-specific 
solutions.
Some vendors appeared reluctant to invest the significant resources needed to 
implement these changes, particularly where they only had a small presence in the 
English market. Other suppliers (and particularly those with a stronger foothold in 
and expectation of a larger share of the market) were deploying strategies to create 
England-specific versions of the products. However the challenge seemed to be 
more substantial than they had anticipated. As they began to implement these sys-
tems in English hospitals, they were confronted by growing numbers of requests to 
adapt the systems to local practices and preferences, which forced them to take on 
board multiple cycles of modification to their products. However at the time of the 
study, with only a handful of hospitals having implemented their system, the major-
ity of these systems were in the early stages of being ‘anglicized’. Hence, what we 
observed were products in their infancy with respect to English-specific require-
ments which arose as a result of differences in national systems and policies (e.g. 
between private insurance-funded health care in the United States of America 
[USA] and the public-funded UK NHS) and particular hospital practices (e.g. dif-
ferences in discharge processes). Some of these overseas suppliers had prior experi-
ence and knowledge of the English market. However they tended to develop their 
English version as an extension of their current non-English HEPMA system. We 
interviewed one supplier which had had live implementations in England of an older 
product for over a decade, but which was also offering its new HEPMA product to 
the English hospitals.
…at that point after several hospitals [in the USA] were up running live and stable with the 
software that’s pretty much the version that we took as our initial like U.K. kind of starting 
point… And basically where we started there were certain items that we knew, we knew were 
going to be different, for example in the U.K. wait lists, 18 week waiting, CDS reporting those 
are like three kind of big areas that, you know, don’t exist in the U.S. [American] software so 
we literally had to start with some of those areas and we just started from what we knew the 
requirements were in the [Old Product Name] environment and fit those to the, you know, the 
[New Product Name] product, you know, the new version.(Supplier Interview, P7)
NHS England is seen as a target for many overseas suppliers from Europe and the 
English-speaking world, though it is only a secondary market for many U.S.A. pro-
ducers. It is not uncommon for systems to be initially developed for local customers 
within a national market before being redeveloped for the international markets 
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(Pollock and Williams 2008). As a result, system architectures may be sub-optimal 
for the English market. Users who were attracted by the powerful functionalities 
offered by non-English systems found themselves caught in an unanticipated and 
slow process of joint system redevelopment with the supplier in a protracted imple-
mentation. Suppliers entering the English HEPMA market found themselves need-
ing to address in a compressed timeframe: (1) the NHS policy context and generic 
English hospital’s needs; and (2) the widely differing specific needs of individual 
adopting hospitals. This in turn called for some way of prioritizing user require-
ments and selectively developing solutions.
9.2.3  Suppliers’ Configuration and Customization Strategies
Suppliers of packaged organisational technology solutions need to develop effective 
strategies for addressing the diversity of user demands for modifications and new func-
tionality. Experienced suppliers had learnt the need for strategies to cater for increas-
ing diversity as their user-base grew in size. This required them to develop a strategic 
vision for their software product and its longer-term development, to keep control over 
the overall architecture of their product as it moved forwards, in the face of the plural-
ity of adopter demands. This allowed them to decide which change requests they 
would entertain, which changes they would be unable to support, and which changes 
could only be undertaken by end-users themselves (Pollock and Williams 2008).
In order to retain overall control over architecture in the face of diverse users, 
software packages are designed around a basic set of organisational functionalities - 
a ‘generic kernel’ (Pollock and Williams 2008). Libraries of ‘templates’ are built 
upon this kernel, catering for commonly encountered workflows and practices. 
Such software packages are ‘user-configurable’, meaning that they incorporate pre- 
programmed features, which can be selected to meet the needs of various environ-
ments through setting up parameters rather than rewriting program codes (Davenport 
2000). However if the range of pre-defined configurations is limited and does not 
meet particular user needs, adopters may be forced to seek to alter the programme. 
Issues then arise about whether this will be incorporated into the package (with 
programming and testing imposing a significant effort and expense for the supplier) 
or whether it will be an ad-hoc customization (which the adopter may have to pay/
take responsibility for). If too many local customizations are made by an adopter, 
reliability may suffer and upgrades may become difficult to implement (Fincham 
et al. 1995).
In the case of HEPMA systems in England, suppliers were pursuing various 
product development strategies but had made very uneven progress in developing 
their strategies. Some had rather rudimentary arrangements for incorporating user 
requirements into the system. Others had begun to develop a more organised 
approach to assessing change requests, generalizing needs and building system 
enhancements. Moreover, at this stage, most HEPMA solutions in England seemed 
to be ‘too limited’ in terms of the configurability they offered (the range of pre- 
programmed options that the user could draw upon) in relation to the diversity of 
adopter practices and requests. In our observation of user group meetings, we 
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frequently encountered instances where the majority of users asked for a particular 
configuration that was not offered by the system.
9.2.4  Localized Adopter Practices Versus Generic Systems
The healthcare context is distinctive in terms of the enormous diversity in specific 
hospital procedures and individual ways of working. Despite the existence of pro-
fessional NHS policy guidelines, each NHS hospital is a separate legal entity. It 
has its own local practices and standard operating procedures. So in performing the 
day-to-day activities, rather than merely complying with a set of professional 
guidelines, hospital employees are also expected to abide by the localized operat-
ing procedures. This was seen as one of the most significant factors leading to the 
complexity of HEPMA systems uptake in England. Interviews with users indicated 
that there were no pre-defined best practices in the health sector because there was 
still no consensus about what is best. Suppliers, though aware of the differences 
in localized practices, emphasised the need to introduce standards to the sector.
…every NHS trust in the country considers themselves to be different… if you give them a 
standard OBS [output based specification]… they make it unique to them… every question 
[on the OBS] has a nuanced, has a little twist in there… (Comment in supplier event)
The implementation of generic HEPMA systems foregrounded these variations in 
practices. Operational differences between hospitals became visible, which had not 
previously been evident. The lack of standard practices became particularly apparent 
in implementing systems with higher levels of integration and complexity compared 
to standalone applications. The diversity of practices was not only hospital-specific. 
Practices varied between departments and specialties, making it difficult for stan-
dard applications to cater for the needs of all wards within a hospital.
9.2.5  ‘Untamed’ Adopter Demands?
Adopters emphasized the particularity of hospital procedures and practices. 
However their responses highlight the lack of adequate awareness amongst users 
about the exigencies of packaged applications and in particular the trade-off between 
the costs of customization versus adapting processes to functionality in the package. 
This resulted in users having what others portrayed as rather unrealistic, indeed 
‘untamed’, expectations of packaged HEPMA solutions. In this respect, users’ 
expectations from packaged solutions were more in line with what might be 
expected from bespoke (tailored) information systems. Thus many users expressed 
a desire for local practices to be directly incorporated into the system.
…we are all doing the same job but we are managing the processes differently, so when we 
implement technologies we all want to implement it in our own way (Adopter Interview, P1)
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…some of the changes we are asking [Product_Name] for are things that individual 
Trusts [hospitals] do… (Adopter Interview, P4)
Given these expectations, hospitals felt they should have direct links with the ven-
dor company to develop their specific requirements.
So companies I’ve worked for before have always had […] a user that partly worked in the 
Trust [hospital] and partly worked for them [in the vendor company] so that they are a cur-
rent user. So they knew the problems so that they could take that back to the [vendor] com-
pany and already start to look at ways of sorting that out. (Adopter Interview, P2)
Suppliers referred to escalating adopter expectations as “over-aspirational func-
tional specifications” (Comment in supplier event). They also highlighted the need 
for early alignment of user expectations and actual system purposes and functions.
…aligning expectations if that managed earlier then everyone is on the same page to begin 
with… (Comment in supplier event)
A further problem arose from insufficient knowledge about what the actual needs of 
hospitals were. Both users and vendors expressed concerns about uncertainty sur-
rounding users requirements.
…electronic prescribing and medical administrations are quite complex. Until there is kind 
of more experience or hospitals on these systems it’s harder to get some kind of consensus 
on what are the features and what isn’t. (Adopter Interview, P4)
We further noted a lack of knowledge in English hospitals of both HEPMA solu-
tions and of the implementation and use of packaged applications more generally. 
One issue that, will be the subject of a future paper, concerns the limited circulation 
of experience in IT procurement and implementation within the NHS. Many of the 
staff who played a central role in a particular hospital implementation then went 
back to their health professional role. Apart from a small number who moved over 
to work for technology suppliers, there was no ready way of carrying forward and 
exploiting this expertise within NHS professional structures.
9.3  Discussion
Vendors of HEPMA applications are investing significant effort in expanding their 
market base internationally. Hospitals in England, in turn, appear keen to implement 
systems that have the potential to deliver the widely anticipated benefits of such 
systems. We found that despite this willingness from both sides, for the various 
reasons considered above, progress with implementing these systems in England is 
proceeding slowly. To understand the underlying reasons we have developed a 
broader analytical framework based upon this work and our earlier research into the 
evolution of Enterprise Systems.
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9.3.1  Analysing the Long-Term Evolution of Information 
Infrastructure
The concept of installed based, which unites the contributions in this volume, was 
coined to capture tensions arising in the development of electronic Information 
Infrastructures (IIs) – defined as systems of (computer-based) systems that support 
an increasingly wide range of tasks across an ever-more extensive base of users. 
Efforts to standardize functions around specific existing users and uses may impede 
the extension of an infrastructure to new users and uses (Hanseth et al. 1996). This 
concept has informed various development and implementation strategies to pre-
vent lock-in around existing configurations and provide flexibility to allow new 
functionality to be taken on board (Grisot et al. 2014). The II discussion, however, 
has largely been at the level of the ‘cultivation’ of individual organisational informa-
tion infrastructures.
Our research into the development and implementation of Enterprise Systems 
(ES) and other corporate information infrastructures (Pollock and Williams 2008) 
suggests that we need to analyse these developments not just at the level of particu-
lar infrastructures and organisations but also across communities of vendors and 
their adopters (Koch 2007). We have studied the development and implementation 
of these kinds of highly complex technologies over three decades (Pollock and 
Williams 2008). This extended timeframe of enquiry has provided insights into both 
the evolution of these technologies and the arrangements for their development and 
implementation. In the 1980s, initial attempts to supply what were then known as 
Computer Aided Production Management (CAPM) systems as COTS packaged 
solutions were characterized by sharp mismatches between supplier offerings and 
user needs. Our subsequent research allowed us to observe how these offerings have 
‘co-evolved’ with their user communities. ES Suppliers have learnt how to develop 
and exploit close links with their adopter communities to develop generic solutions 
that can be used and be useful across a wide range of adopter organisations. Our 
insights derive from extending the scope of empirical research not just laterally, 
across arrays of vendors and adopters etc., but also along an extended ‘longitudinal’ 
timescale (Pollock and Williams 2008).
CAPM refers to the set of technologies that resulted from a UK government initi-
ated program during the 1980s. By adding new functions onto existing Manufacturing 
Resource Planning (MRP II) technologies, CAPM sought to offer integrated pack-
aged solutions to production control and coordination tasks. It was seen as a step-
ping stone towards Computer Integrated Manufacture (CIM) (Williams 1997; 
Webster and Williams 1993). In response to the promotion efforts of government 
(the Department of Trade and Industry, the Science and Engineering Research 
Council) and other influential actors such as consultants and vendors, a large num-
ber of suppliers from different fields were attracted to offer “CAPM” solutions 
(Clark et al. 1992; Newell and Clark 1990). The availability of government funds 
encouraged many vendors of MRP II and related systems to project their products 
under the name CAPM. This resulted in a swarming of supplier offerings around the 
concept of CAPM, with functionalities being added to existing products to fulfil the 
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expectations of policymakers, pundits and adopter organisations (Webster and 
Williams 1993). However attempts to implement CAPM packages ran into sharp 
difficulties which resulted in up to 50% of systems being abandoned. The most 
immediate features were:
 1. An acute lack of fit between the presumptions underpinning the packaged solu-
tion and the circumstances of particular adopter organisations; and,
 2. The CAPM products launched initially were often still-unfinished with various 
new functionalities added that were poorly integrated (Webster and Williams 
1993).
As a result, would-be adopters found themselves drawn in to an unplanned col-
laboration with suppliers in a struggle to get these standard packages to work in the 
adopting organisation’s particular circumstances. In this process we saw a more or 
less radical reworking of the solution, with some functionalities being abandoned 
and new functions emerging.
The immediate result of this accelerated development and diffusion was the 
launch of products that were often immature and unstable (Webster and Williams 
1993). In the subsequent decade however a new generation of ERP and ES systems 
emerged, building very directly upon these applications. They incorporated the 
underpinning philosophy and many technical elements of CAPM and its predeces-
sors – in particular the idea of connecting multiple functions across the enterprise 
with an integrated and interoperable system – and were also heralded as a stepping 
stone to CIM (Xue et al. 2005; Pollock and Williams 2008). The concept of ERP 
began gaining momentum through the 1990s, particularly as firms renewed their 
systems to avoid anticipated ‘millennium bug’ problems. A range of successful 
products emerged. Some (e.g. JDEdwards, Peoplesoft) fell by the wayside as the ES 
product market restructured, leaving global giants such as Oracle and SAP in domi-
nant positions. As a result we find that today SAP’s R3 system has been adopted by 
the majority of FTSE 100 and Fortune 1,000 firms CIM (Pollock and Williams 
2008).
The success of ESs built upon several decades of experience with its predecessor 
technologies (stock control, production control, Material Requirements Planning 
[MRP], MRP II) (Williams 1997). There are two crucial features underpinning 
these developments:
 i. Successful suppliers of packaged ES solutions had, over time, elaborated sophis-
ticated generification strategies, through which they elicited, aligned, sifted and 
sorted the diverse requirements of their communities of adopters
 ii. Permanent linkages were established within the ES community – in particular 
through user-clubs linking suppliers and adopter communities (Mozaffar 2016).
The subsequent success of ERP/ES was rooted in the mutual adaptation of both 
adopter organisation practices/processes and packaged features (Hong and Kim 
2002; Leonard 2011).
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9.3.2  Analysing the State of the Technology Market/Technology 
Field
These considerations suggest that if we wish to understand difficulties encoun-
tered in HEPMA procurement and implementation, it may be helpful to analyse 
the evolution and current state of development of the HEPMA market in 
England, drawing parallels and insights from our studies of the ES technology 
field.
The idea of the maturation of technology fields can be traced back to classic 
1970s studies by Abernathy and Utterback who proposed a three stage model 
(Abernathy and Utterback 1978). In an initial experimentation phase, we see the 
rapid entrance of diverse and changing products into a new market, the ultimate 
direction of which is still unknown. As the market and the applications of the 
technology become better appreciated by suppliers and adopters, in the next, tran-
sitional phase, the market begins to converge around what is known as a ‘domi-
nant design’ with broadly comparable characteristics. In the mature phase, as 
dominant designs become established, we find concentration of the market around 
a smaller number of products with higher performance. The focus of supplier 
efforts shifts from differentiation to enhancing performance and lowering costs 
within an existing product paradigm. Similar stage models have been advanced to 
analyse the cyclical evolution of product markets including the software product 
life cycle (Agarwal and Tripsas 2008; Fincham et al. 1995). ‘Institutionalist’ 
organisation theorists have described the homologous processes by which new 
‘technological fields’ (Pollock and Williams 2011; Swanson and Ramiller 1997, 
2004) emerge and take shape by establishing consensus amongst communities of 
vendors, consultants and adopters. The establishment of a technological field 
greatly reduces uncertainties about the characteristics of a technology both for 
vendors and customers. They are coupled with the emergence and stabilisation of 
classifications of technologies and criteria for their assessment. Here we reject 
simplified (e.g. technology management) approaches which take for granted the 
formation of technological fields and their progression, once established, to matu-
ration and seek a more dynamic, processual account of the evolution of techno-
logical fields which explores how boundaries and names may be recast and 
maturation may be reversed by the emergence of new technical solutions or busi-
ness models (Fincham et al. 1995). In the ES field we saw the emergence of new 
kinds of knowledge intermediaries – industry analysts like Gartner Inc. – which 
capture and collate community experience to advise adopters about available soft-
ware products and their vendors. By overcoming the asymmetry of access to 
information between vendor and adopter this provides the ‘knowledge infrastruc-
ture’ needed for the operation of the IT markets for these complex software prod-
ucts whose capacities and fit to the needs of particular adopter organisations 
cannot be readily established, for example, by inspection (Pollock and Williams 
2011, 2016).
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9.3.3  Is the HEPMA Market Replicating the Path of ERP?
Our study of the evolving nature of the HEPMA market in England, exhibits some 
interesting and insightful parallels with the earlier history of integrated systems in 
the commercial sector: ERP and its predecessor CAPM Systems. This drew our 
attention to (i) how vendors developed generification strategies to create generic 
solutions that could bridge to a wide-range of adopter contexts, (ii) the development 
of multiple webs of relations between vendors and adopters through which knowl-
edge about user requirements and vendor offerings could be exchanged, and (iii) 
how new knowledge intermediaries emerged to advise adopters in their procure-
ments. We were able to assess the extent to which comparable arrangements had 
emerged in the UK HEPMA market.
9.3.4  The English HEPMA Market Is Still in an Emergence Stage
The comparison with the ES case suggests that the HEPMA market in England is 
still in an early stage of emergence/growth. Various suppliers have entered the mar-
ket with each one having a relatively small number of implementations in progress 
(Mozaffar et al. 2014). The HEPMA market exhibits a high technical variety in 
development of products with diverse features and forms. These products originate 
from different geographical and technical backgrounds and are offered in different 
forms with dissimilar features and functions. This would suggest that their techno-
logical features have not yet become de facto standards or ‘dominant designs’ 
(Agarwal and Tripsas 2008; Utterback 1974) in the English market. In this market 
there is still no accepted architecture, established use practice or evaluation criteria 
to guide and constrain the efforts of suppliers and adopters (Sheikh et al. 2014). This 
also contributes to diverse supply strategies and use of numerous terminologies and 
definitions all of which act as barriers to smooth and rapid adoption.
The lack of shared understanding creates a problem for potential adopters in 
understanding the options available (Helm and Salminen 2010; Jalkala and Salminen 
2010). It also creates uncertainty for vendors about customer requirements. End 
user requests are typically more diverse than anticipated. Suppliers have difficulties 
in responding systematically to this diversity (Agarwal and Tripsas 2008; Adner and 
Levinthal 2001) given this lack of clear ‘preferences’ (Clark 1985). The market 
remains in the experimental stage with new products and suppliers still emerging.
Suppliers had adopted different approaches to respond to the diverse needs of the 
English market. On one end of the spectrum were those suppliers which had already 
grown and stabilized their products in other national markets. Some offered their 
international products with only minor modifications to cater for the English hospi-
tals’ needs. Others had embarked upon concerted attempts to re-design and develop 
their applications around the particular needs of English hospitals. When we con-
trast the HEPMA and ES market today, we can see that HEPMA vendors had not 
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yet developed ‘generification strategies’ (Pollock and Williams 2008) in relation to 
establishing mechanisms to decide which of the diverse array of user requirements 
would be taken on board in their core product but instead tended to respond to 
requests in an ad-hoc manner. Conversely, since HEPMA systems did not yet incor-
porate sufficient libraries of common workflows that the user could switch on in 
configuring the system, rather than by rewriting code, adopter organisations felt 
compelled to submit customisation requests.
The lack of consensus amongst adopter and vendor communities and domain 
experts indicates that the technological field is still developing. The field has not yet 
developed structures and actors to mobilize consensus and set the boundaries of 
technology (a role carried out in other sectors by industry analysts like Gartner 
(Pollock and Williams 2011), and by entities such as the Health Information 
Technology Standards Committee and certifying organisations). These could help 
reduce procurement uncertainties in various ways: enabling development of generic 
cases for innovations, creating a space for comparison of different artefacts and sup-
pliers, and helping users come to more realistic and realizable expectations about 
HEPMA functionalities and its effective use.
9.3.5  Conclusions
We identified several tensions in design and implementation of HEPMA systems in 
England. The problems can be sorted into six categories: (1) products derived from 
non-clinical systems proved problematic in England’s increasingly patient-centred 
health system; (2) the process of Anglicization of systems by suppliers from other 
countries of origin needs to be given sustained attention; (3) the healthcare sector 
has particularly diverse needs and practices which run counter to the goals of generic 
applications; (4) current products are limited in configurability in relation to the 
diversity of adopter requirements which results in escalating customisation requests 
(5) rather than respond in an ad-hoc manner to proliferating customisation requests 
vendors need to develop generification strategies (perhaps through user groups) to 
sift, sort and prioritise these requests to keep control over the strategic development 
of their product and (6) adopters have little awareness of the exigencies of exploit-
ing COTS solutions resulting in ‘untamed’ demands from packaged applications.
We conclude that effort to promote HEPMA arguably attracted a range of rela-
tively unfinished solutions into the market prematurely. In this process neither the 
developers nor the adopting organisation were prepared for the complexities of 
matching generic products to a diverse adopter context. This echoes elements of 
previous UK experience with CAPM/ERP systems. We infer that, although policy 
incentives can be effective in achieving adoption (Aarts and Koppel 2009), they 
may also have accelerated premature purchase of immature solutions. This suggests 
a need for a gradual move in the market for such immature technology. So instead 
of suppliers seeking rapid large-scale implementation of their products, they may 
need to take a more deliberate and purposeful approach in developing their products 
for new markets, which will involve partnering with specific institutions until many 
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of the kinks are worked out. Also adopting hospitals need to be more clear and real-
istic in expressing their needs in relation to packaged applications. Furthermore, 
more effective mechanisms are required to bridge the gap between the generic stan-
dardized technological solutions and the particularity of national and local needs. In 
order to achieve this, suppliers must not underestimate user diversity. They need to 
develop strategies to deal with such diversities in the market. At the same time the 
adopting organisations need to become pre-aligned to these packages and around 
views within the Health Service of best practice. In short, what is needed is a co- 
evolution of organisation and technology together. Public policy might usefully be 
geared towards promoting – and allowing time for – such extended engagement 
(though competitive public procurement/tendering arrangements may not facilitate 
this kind of supplier-user engagement) (Lee et al. 2015).
Finally, we suggest that HEPMA is not the final stage in the process of develop-
ing health IIs. Though conceived as a discrete, pharmacy technology, HEPMA sys-
tems linked the pharmacy to the ward, and went beyond the point of prescription to 
the administration of medicine throughout and after their hospital stay. As a result 
HEPMA systems involved a wide range of stakeholders across the hospital junior 
doctors, consultants, nurses across different specialities, with their various work 
practices and requirements (a point which becomes crucial when we consider the 
difficulties catering for diverse ‘end-user’ requirements). HEPMA moreover 
became – at least in the historical trajectory of English hospitals - bound up with the 
integration of a growing range of digital information services (most immediately 
laboratory results) at the point of healthcare delivery throughout the hospital. Once 
introduced, these packaged HEPMA solutions became the starting point for the 
continued extension of systems and their integration with other systems within the 
hospital and beyond (for example discharge letters to general practitioners). HEPMA 
systems are becoming core components of hospital health information infrastruc-
tures. We suggest that HEPMA has served as a stepping stone to information inte-
grated health care (in a way that parallels the earlier history of enterprise systems in 
industrial organisations (Fleck 1988)). Our research has identified a range of imme-
diate problems associated with development, procurement and implementation of 
HEPMA systems in the English healthcare system. Our comparison with the prior 
experiences with ES allows us to see these as part of a longer-term social learning 
process (Sørensen 1996). To overcome these challenges, vendors and adopters must 
understand their current and potential user-base and develop strategies to address 
the heterogeneities and multiplicities of adopter requirements and practices. This 
diagnosis in turn provides important lessons for attempts to build health information 
infrastructures. England, as one of the leading countries in Europe in adoption of 
such technologies, can be seen as a site of innovation in which the market and prod-
ucts are being shaped simultaneously. Similar patterns in terms of difficulties of 
HEPMA adoption have been observed in many countries (Mäkinen et al. 2011; 
Aarts and Koppel 2009). However England is one of the leading countries with the 
highest rates of HEPMA adoption (Aarts and Koppel 2009; Van Dijk et al. 2011; 
Schoen et al. 2006), and other countries may benefit from analysis of UK 
experiences.
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The large scale of the NIHR-funded research programme allowed us, rather 
exceptionally, to study the implementation of a range of supplier offerings in mul-
tiple sites and over an extended period. We identified sharp echoes between these, 
still emerging, experiences and findings from our own personal research conducted 
over three decades into the evolution of ES solutions. These highlighted the need to 
go beyond single site snapshot studies of information infrastructure implementation 
and also examine the development of the component technologies (in this case dis-
crete and integrated packaged HEPMA solutions) amongst closely coupled com-
munities of developers and adopters of particular products and within evolving 
technological fields (Pollock and Williams 2008, 2016). The need to understand 
longer-term evolution of products across a community requires us to go beyond (or 
radically re-specify) the concept of Installed Base. Here we have drawn upon a 
long-established tradition of work from organisational studies and related perspec-
tives: notably the institutionalist concept of technology field and related work on 
product life-cycles. These have provided a helpful framework to guide the extension 
of our detailed ethnographic study beyond single sites and moments to encompass 
longer-term developments across vendor/adopter communities. Our work here has 
focused upon the ‘community’ of vendors, adopters and consultants linked to a par-
ticular technology. This does not however imply a ‘flat’ approach to community 
which risks portraying the co-evolution of technologies and their adopters as a sim-
ple process of joint learning and consensus building. Instead our studies of both ES 
and HEPMA highlight the overlapping webs of relationship through which these 
‘communities’ are structured and segmented into a complex topology (Pollock and 
Williams 2016; Mozaffar 2016). Here we find a contradictory process in which 
diverse players grapple to accommodate goals in tension – for example supplier 
efforts to standardize technologies and adopter desires to differentiate systems 
around their particular (local or disciplinary) methods of working. These play out 
and need to be analysed over multiple cycles of design and implementation.
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